Skip to main content
. 2022 Jul 8;16(12):1862–1873. doi: 10.1093/ecco-jcc/jjac098

Figure 5.

Figure 5

Kaplan–Meier Curves showing differences in probability in reaching a composite outcome of escalation of immunomodulator/biologic therapy, corticosteroid use, IBD related hospitalisation, and surgery during 12 months of follow-up based on threshold values of baseline biomarkers [faecal calprotectin, fCal, >250 µg/g<; faecal myeloperoxidase, fMPO, fMPO > 26 µg/g<]. IBD, inflammatory bowel disease.